Breast milk study for mothers with past vivax malaria
Part of Infections clinical trials.
This study tests a medicine given to mothers after childbirth to see how it passes into breast milk and if it is safe for babies. It may help prevent malaria relapse in mothers who have had vivax malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You and your baby have normal G6PD enzyme activity (a blood test checks this)
- You gave birth to a single, live baby within the last 48 hours
- You and your baby do not have malaria (tested with a rapid test)
- You plan to breastfeed your baby exclusively for at least 2 months
- You have had vivax malaria before (as noted in your health records)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
This trial tests a shorter course of the drug primaquine to prevent relapse of vivax malaria, a recurring type of malaria. It may offer a faster recovery with fewer doses.
This trial tests how well the drug primaquine works for people with vivax malaria who have intermediate or low levels of an enzyme called G6PD. It aims to find safe and effective treatment options for this group.
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
Hear when a new Drug Pharmacokinetics in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.